Situation

$300M+ subsidiary of $3B public medical device company. Subsidiary business unit operated globally with significant market shares in the US and German premium segments of their business. Acquisitions represented various opportunities to dramatically increase market share through technology additions, dual branding to address the middle tier segment and improved penetration in developing markets.

Action

3 separate sub $100M founder owned medical devices companies acquired over multiple years. Businesses were carefully integrated to respect founder deal agreements while at the same time leveraging the power of the larger acquiring organization. Total invested capital $250M+. A variety of actions were taken to optimize the acquisitions including manufacturing transfer (2 of 3), product portfolio expansion (3 of 3), management consolidation (2 of 3) and geographic expansion (2 of 3).

Result

All acquired companies performed well in excess of acquisition models and remain within the acquiring company today.